PLATELET COUNT ABNORMAL side effect
What is PLATELET COUNT ABNORMAL ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PLATELET COUNT ABNORMAL and Recently Reported Side Effects
PLATELET COUNT ABNORMAL and 15 most Active Side Effect polls
PLATELET COUNT ABNORMAL and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with PLATELET COUNT ABNORMAL
ARGATROBAN BEVACIZUMAB BORTEZOMIB CARBOPLATIN CISPLATIN CLOLAR CYCLOPHOSPHAMIDE CYTARABINE DEPAKOTE DILANTIN FLUOROURACIL GEMCITABINE GEMZAR OCTAGAM REVLIMID SUTENT TEMOZOLOMIDE TRASTUZUMAB TRIPACK ZYPREXARevlimid Side Effects Report #5647335-2
Physician from UNITED STATES reported REVLIMID problem on Nov 05, 2007. Female patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: platelet count abnormal, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL ; 15 MG, 1 IN 1 D, ORAL. Patient recovered.
Fluorouracil Side Effects Report #5546749-9
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2007. Female patient, weighting 181.0 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: platelet count abnormal, . FLUOROURACIL dosage: 8000 MG. During the same period patient was treated with MITOMYCIN. Patient was hospitalized. Patient recovered.
Trastuzumab Side Effects Report #5404558-5
Physician from SPAIN reported TRASTUZUMAB problem on July 24, 2007. Male patient was diagnosed with transitional cell carcinoma and was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: platelet count abnormal, . TRASTUZUMAB dosage: 4 MG/KG, UNK. During the same period patient was treated with CISPLATIN, GEMCITABINE, GLICLAZIDE, OMEPRAZOLE, ADALAT. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5753373-1
GEMZAR problem was reported by a Physician from UNITED STATES on May 21, 2008. Male patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: platelet count abnormal, pneumonia, sepsis, . GEMZAR dosage: unknown. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5691875-7
Consumer or non-health professional from UNITED STATES reported TEMOZOLOMIDE problem on Apr 01, 2008. Male patient, weighting 200.4 lb, was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: platelet count abnormal, . TEMOZOLOMIDE dosage: 2200 MG. During the same period patient was treated with ZOFRAN. Patient recovered.
Trastuzumab Side Effects Report #5362820-9
TRASTUZUMAB problem was reported by a Physician from SPAIN on June 04, 2007. Male patient was diagnosed with transitional cell carcinoma and was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: platelet count abnormal, . TRASTUZUMAB dosage: 4 MG/KG, UNK. During the same period patient was treated with CISPLATIN, GEMCITABINE, GLICLAZIDE, OMEPRAZOLE, ADALAT. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5484043-5
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Oct 09, 2007. Female patient, weighting 134.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, platelet count abnormal, white blood cell count abnormal, . CYCLOPHOSPHAMIDE dosage: 1267 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, VELCADE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Cisplatin Side Effects Report #5456678-7
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 17, 2007. Female patient, weighting 131.8 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count abnormal, platelet count abnormal, white blood cell count abnormal, . CISPLATIN dosage: 79 MG. During the same period patient was treated with TOPOTECAN. Patient recovered.
Argatroban Side Effects Report #5472251-9
Physician from UNITED STATES reported ARGATROBAN problem on Sept 10, 2007. Male patient, 59 years of age, weighting 142.0 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, platelet count abnormal, . ARGATROBAN dosage: unknown. During the same period patient was treated with NORVASC, LASIX, PREDNISONE, DEXAMETHASONE, PROTONIX, SENNA, COLACE, INSULIN. Patient was hospitalized. Patient recovered.
Cisplatin Side Effects Report #5474516-3
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2007. Female patient, weighting 132.9 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count abnormal, platelet count abnormal, white blood cell count abnormal, . CISPLATIN dosage: 78.5 MG. During the same period patient was treated with TOPOTECAN. Patient was hospitalized. Patient recovered.
Carboplatin Side Effects Report #5429299-X
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Aug 27, 2007. Female patient, weighting 116.8 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, platelet count abnormal, white blood cell count decreased, . CARBOPLATIN dosage: 730 MG. During the same period patient was treated with TAXOTERE, TAXOL. Patient recovered.
Argatroban Side Effects Report #5802555-9
ARGATROBAN problem was reported by a Physician from UNITED STATES on Sept 10, 2007. Male patient, 59 years of age, weighting 142.0 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time shortened, platelet count abnormal, . ARGATROBAN dosage: unknown. During the same period patient was treated with NORVASC, METOPROLOL TARTRATE, LASIX, PREDNISONE, DEXAMETHASONE, PROTONIX, SENNA, COLACE. Patient was hospitalized. Patient recovered.
Fluorouracil Side Effects Report #5268158-2
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on Mar 14, 2007. Male patient, weighting 260.4 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: neutropenic sepsis, platelet count abnormal, stomatitis, white blood cell count abnormal, . FLUOROURACIL dosage: 6540 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient died on 03/09/2007.
Gemcitabine Side Effects Report #5279949-6
GEMCITABINE problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Male patient, weighting 257.7 lb, was diagnosed with sarcoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: petechiae, platelet count abnormal, pyrexia, . GEMCITABINE dosage: 2400 MG D1, D8 IV. During the same period patient was treated with CAPECITABINE, LOVENOX, NEXIUM, TYELNOL, RED BLOOD CELLS, PLATELETS. Patient recovered.
Revlimid Side Effects Report #5587665-6
Physician from UNITED STATES reported REVLIMID problem on Dec 27, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, blood viscosity increased, platelet count abnormal, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient recovered.
Bortezomib Side Effects Report #5546752-9
BORTEZOMIB problem was reported by a Health Professional from UNITED STATES on Dec 07, 2007. Male patient, 61 years of age, weighting 203.9 lb, was diagnosed with mantle cell lymphoma and was treated with BORTEZOMIB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haemoglobin abnormal, platelet count abnormal, rhinitis, sinusitis, . BORTEZOMIB dosage: 2.7MG D1+4 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5549623-7
Physician from UNITED STATES reported CLOLAR problem on July 03, 2007. Male patient, child 12 years of age, weighting 69.23 lb, was diagnosed with acute lymphocytic leukaemia, leukaemia recurrent and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: klebsiella infection, leukaemia recurrent, platelet count abnormal, sepsis, white blood cell count abnormal, . CLOLAR dosage: 40 MG/M2 DAILY IV. During the same period patient was treated with CYTARABINE, PREDNISONE, ZOFRAN, PENTAMIDINE ISETHIONATE. Patient was hospitalized. Patient recovered.
Dilantin Side Effects Report #5565475-3
DILANTIN problem was reported by a Physician from UNITED STATES on Dec 06, 2007. Female patient, weighting 180.4 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: coeliac disease, dermatitis herpetiformis, platelet count abnormal, . DILANTIN dosage: unknown. During the same period patient was treated with DAPSONE, CENESTIN, PRILOSEC, LEVOTHYROXINE, ZANTAC, XALATAN, PREDNISONE. Patient recovered.
Bevacizumab Side Effects Report #5525838-9
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Nov 12, 2007. Female patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hypertension, interstitial lung disease, platelet count abnormal, . BEVACIZUMAB dosage: 5 MG/KG, UNK. During the same period patient was treated with ISOVORIN, FLUOROURACIL, OXALIPLATIN, MIYA BM, NORVASC, URSO, TATHION, MAGNESIUM OXIDE. Patient died on 10/28/2007.
Revlimid Side Effects Report #5527391-2
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 15, 2007. Female patient, 59 years of age, weighting 144.4 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: hypotension, neutropenia, platelet count abnormal, renal failure acute, rhabdomyolysis, white blood cell count decreased, . REVLIMID dosage: 15 MG, Q DAY, ORAL. Patient was hospitalized. Patient recovered.
Zyprexa Side Effects Report #5480355-X
Physician from FRANCE reported ZYPREXA problem on Sept 28, 2007. Male patient, 31 years of age, was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: low density lipoprotein increased, overdose, platelet count abnormal, . ZYPREXA dosage: 20 MG, DAILY (1/D). Patient recovered.
Cisplatin Side Effects Report #5484030-7
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2007. Female patient, weighting 132.9 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, platelet count abnormal, vaginal haemorrhage, white blood cell count abnormal, . CISPLATIN dosage: 78.5 MG. During the same period patient was treated with TOPOTECAN. Patient was hospitalized. Patient recovered.
Tripack Side Effects Report #5492036-7
Physician from UNITED STATES reported TRIPACK AZITHROMYCIN problem on Oct 18, 2007. Male patient, 21 years of age, weighting 160.0 lb, was diagnosed with bronchitis and was treated with TRIPACK AZITHROMYCIN. After drug was administered, patient experienced the following problems/side effects: epistaxis, leukocytoclastic vasculitis, platelet count abnormal, . TRIPACK AZITHROMYCIN dosage: unknown. Patient recovered.
Temozolomide Side Effects Report #5503162-8
TEMOZOLOMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 29, 2007. Female patient, weighting 156.6 lb, was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: nausea, platelet count abnormal, vomiting, . TEMOZOLOMIDE dosage: 5320 MG. Patient recovered.
Octagam Side Effects Report #5443031-5
Consumer or non-health professional from AUSTRIA reported OCTAGAM problem on Aug 13, 2007. Male patient was diagnosed with idiopathic thrombocytopenic purpura and was treated with OCTAGAM. After drug was administered, patient experienced the following problems/side effects: dysphasia, infusion related reaction, platelet count abnormal, . OCTAGAM dosage: unknown. During the same period patient was treated with ATENOLOL, CANDESARTAN, METFORMIN, PANTOPRAZOLE, PREDNISOLONE. Patient recovered.
Cyclophosphamide Side Effects Report #5443340-X
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2007. Female patient, weighting 148.8 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, platelet count abnormal, white blood cell count abnormal, . CYCLOPHOSPHAMIDE dosage: 1050 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.
Cytarabine Side Effects Report #5392147-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 18, 2007. Female patient, weighting 167.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: epistaxis, mouth haemorrhage, platelet count abnormal, skin haemorrhage, . CYTARABINE dosage: 16650 MG. Patient recovered.
Cytarabine Side Effects Report #5392147-0
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2007. Female patient, weighting 167.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: epistaxis, mouth haemorrhage, platelet count abnormal, skin haemorrhage, . CYTARABINE dosage: 16650 MG. Patient recovered.
Cyclophosphamide Side Effects Report #5732817-5
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 07, 2008. Male patient, weighting 166.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: lymphopenia, neutrophil count abnormal, platelet count abnormal, . CYCLOPHOSPHAMIDE dosage: 1188 MG. During the same period patient was treated with PENTOSTATIN, RITUXIMAB. Patient was hospitalized. Patient recovered.
Depakote Side Effects Report #5740976-3
DEPAKOTE problem was reported by a Health Professional from FRANCE on May 09, 2008. Male patient, 62 years of age, was diagnosed with bipolar disorder, diabetes mellitus, depression and was treated with DEPAKOTE. After drug was administered, patient experienced the following problems/side effects: haemoglobin abnormal, neutrophil count abnormal, platelet count abnormal, red blood cell abnormality, treatment noncompliance, . DEPAKOTE dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, INSULIN, REBOXETINE. Patient recovered.
Sutent Side Effects Report #5344230-3
Health Professional from UNITED STATES reported SUTENT problem on May 31, 2007. Female patient, weighting 172.4 lb, was diagnosed with glioblastoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, platelet count abnormal, . SUTENT dosage: 50 MG DAILY PO. During the same period patient was treated with DEXAMETHASONE, ALTACE, TOPROL, INSULIN, CRESTOR, TOLAZAMIDE, PREVACID, REQUIP. Patient recovered.
Cytarabine Side Effects Report #5175281-X
CYTARABINE problem was reported by a Health Professional from UNITED STATES on Dec 11, 2006. Female patient, weighting 113.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: fungus sputum test positive, neutrophil count abnormal, platelet count abnormal, pyrexia, white blood cell disorder, . CYTARABINE dosage: unknown. Patient was hospitalized. Patient recovered.